[EN] HISTAMINE 4 RECEPTOR PARTIAL AGONISTS, INVERSE AGONISTS OR ANTAGONISTS FOR USE|IN TREATING NON-AUTOIMMUNE UVEITIS<br/>[FR] AGONISTES PARTIELS, AGONISTES INVERSES OU ANTAGONISTES DU RÉCEPTEUR DE L'HISTAMINE 4 DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT DE L'UVÉITE NON AUTO-IMMUNE
申请人:UCL BUSINESS PLC
公开号:WO2014033480A1
公开(公告)日:2014-03-06
The invention provides a compound which is a histamine 4 receptor antagonist, partial agonist or inverse agonist, for use in the treatment of non-autoimmune uveitis. The compound preferably has a structural core comprising a substituted pyrimidine group, such as an aminopyrimidine, diaminopyrimidine or triaminopyrimidine group, a thienopyrimidine, a furopyrimidine, a benzimidazole, an aryl or heteroaryl-fused pyrimidine, an indole, a bicyclic heteroaryl-substituted imidazole or a quinazoline group.